Key to Bibby Scientific's strategy for growth is to invest heavily in both r&d and marketing. The company’s aim is to develop a continuous stream of products that deliver real value to the scientist in terms of functionality, connectivity and performance.
Andy Mooney, Bibby Scientific sales director, said the new office in Singapore would help Bibby expand its geographical footprint and work more closely with customers in the region.
‘Deepening our understanding of the Asian market will lead to the development of products aligned to local customer requirements, and our presence will also enable us to provide a higher level of support to both dealers and end users,’ he said.
Bibby Scientific opens sales office in Singapore
Enables laboratory products supplier to build relationships in whole Asian region
You may also like
Trending Articles
You may also like
Manufacturing
IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility
Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
Manufacturing
Cellistic launches three new iPSC-based GMP platforms to advance immuno-oncology and regenerative therapies
The three new iPSC-derived GMP manufacturing platforms, Echo-T, Echo-Cardio and Echo-Endothelial, expand the company’s Echo portfolio and are designed to improve scalability and manufacturability across immuno-oncology and regenerative medicine programmes